Advocacy Roundtable
This virtual roundtable discussion addresses the latest allergy advocacy issues and answers members’ advocacy questions. Topics include:USP, FDA and state regu…
Legislative Briefs
ACAAI Legislative Briefs
SUPPORT H.R. 4662 – School-Based Asthma Management Program Act
Can't see the PDF preview? Access it here.
Patient Access to Specialty Care – Allergy/Asthma
Can't see the PDF preview? Access it here.
New 2018 MACRA proposal offers major concessions to physicians
Drs. Imbeau, Meadows, Sublett, Fineman and Blaiss met with Mary Sumpter-Lapinski, Health Policy Director, Senate Committee on Health, Education Labor and Pens…
Template for Commenting on FDA Guidelines on Insanitary Conditions
Dear Fellow Allergists:We urge you to submit comments to the FDA on its Draft Guidance on Insanitary Conditions at Compounding Facilities (FDA Docket No. D-226…
We know what’s happening – and we’re working for you.
The American College of Allergy, Asthma and Immunology has been aware of the now infamous EpiPen auto-injector price increases since the early part of this yea…
Advocacy Council contacts WPS Medicare Contractor regarding Immunotherapy Policy
From: Allen MeadowsSent: Tuesday, March 15, 2016 6:29 PMDear Dr. Noel:As the Chair of the Advocacy Council of the ACAAI, and on behalf of our members as well …
WPS’ Response to the Advocacy Council
From: Noel, EllaSent: Wednesday, April 27, 2016 9:00 AMDear Dr. Meadows:WPS GHA has decided to make further changes in the LCD on Immunotherapy after further r…
